Data Foundry

Drug recalls 2024

Potassium Chloride Extended-Release Capsules — Class II drug recall D-0607-2024

Ongoing recall by Glenmark Pharmaceuticals Inc., USA, reported 2024-07-24, distributed nationwide. CGMP Deviations

Recall numberD-0607-2024
Product typeDrug
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmGlenmark Pharmaceuticals Inc., USA, Mahwah, NJ, United States
Recall initiated2024-05-30
Classified2024-07-17
Reported by FDA2024-07-24
DistributedNationwide (US)
Reason classescgmp
NDC68462-0357, 68462-0357-01, 68462-0357-05, 68462-0357-90
Lot numbers17230186, 17230192, 17230213, 17230278, 17230399, 17230406, 17230412, 17230427, 17230444, 17230453, 17230495, 17230574, 17230585, 17230608, 17230629, 17230883, 17230921, 17231087, 17231339, 17231360, 17231711, 17231745, 17231819, 17231820, 17231936, 17231957, 17231998, 17232012, 17232110, 17232114, 17232119, 17232343, APR-30-25, AUG-31-25, DEC-31-24, FEB-28-25, JAN-31-25, JUL-31-25, JUN-30-25, MAR-31-25 and 2 more

Product

Potassium Chloride Extended-Release Capsules, USP, (750 mg) 10 mEq K, 500-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd. Plot No. 2, Phase-2, Pharma Zone SEZ, Pithampur, Dist.-Dhar, Madhya Pradesh 454 775, India, Manufactured for: Glenmark Pharmaceuticals Inc, USA, Mahwah, NJ 07430. NDC 68462-357-05

Reason for recall

CGMP Deviations

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0607-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.